PAVmed Inc PAVM
$4.95
βΌ -2.08%
($-0.11)
🎈 Low Float
🗓️ Earnings Next Week
Open
$5.26
Prev Close
$5.06
Day Range
$4.95 β $5.30
52W Range
$3.85 β $28.44
Market Cap
$35.44M
P/E (TTM)
88.37
Beta
0.54
EPS (TTM)
$-28.72
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-07-27 |
| Shares Out. | 7,160,000 |
| Website | pavmed.com/ β |
| Phone | 12129494319 |
| Employees | 41 |
| Revenue | $22,000 |
| Gross Profit | -$75,000 |
| Net Income | -$1.1M |
| Free Cash Flow | -$6.3M |
| Total Assets | $45.4M |
| Total Liabilities | $20.4M |
| Equity | $25.0M |
About PAVmed Inc
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
PAVmed Inc is a publicly traded company under the ticker symbol PAVM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
8 analysts (2026-07-01)
